|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
55,700,000 |
Market
Cap: |
1.93(B) |
Last
Volume: |
491,968 |
Avg
Vol: |
418,201 |
52
Week Range: |
$19.86 - $42.4 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AtriCure provides treatments for atrial fibrillation (Afib), left atrial appendage management and post-operative pain. Co.'s ablation and left atrial appendage management products are used by physicians during both open-heart and minimally invasive procedures. Co.'s Isolator® Synergy Ablation System is approved by U.S. Food and Drug Administration (FDA) for the treatment of persistent and long-standing persistent Afib concomitant to other open-heart surgical procedures. The EPi-Sense® system is approved by FDA to treat patients with long-standing persistent Afib. All of Co.'s other ablation devices are cleared for sale in U.S., including its other radio frequency and cryoablation products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
5,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$111,250 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
8,600 |
8,600 |
12,100 |
32,268 |
Total Sell Value |
$316,132 |
$316,132 |
$400,377 |
$1,201,409 |
Total People Sold |
2 |
2 |
3 |
5 |
Total Sell Transactions |
2 |
2 |
3 |
11 |
End Date |
2025-03-04 |
2024-12-01 |
2024-06-02 |
2023-06-03 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2025-05-28 |
4 |
S |
$33.44 |
$83,600 |
D/D |
(2,500) |
73,550 |
|
- |
|
White Robert S. |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
112,174 |
|
- |
|
Groves Regina E |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
36,167 |
|
- |
|
Wehrwein Sven |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
34,374 |
|
- |
|
Yuen Maggie |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
14,371 |
|
- |
|
Johnson B Kristine |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
49,810 |
|
- |
|
Telman Deborah H |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
22,184 |
|
- |
|
Nachman Shlomo |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
18,511 |
|
- |
|
Prange Karen |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
23,229 |
|
- |
|
White Robert S. |
Director |
|
2025-05-05 |
4 |
OE |
$22.62 |
$226,200 |
D/D |
10,000 |
106,773 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2025-03-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
706,555 |
|
- |
|
Prange Karen |
Director |
|
2025-03-05 |
4 |
S |
$38.12 |
$232,532 |
D/D |
(6,100) |
17,828 |
|
10% |
|
Carrel Michael H |
President, CEO, & Director |
|
2025-03-01 |
4 |
D |
$38.74 |
$1,701,693 |
D/D |
(43,926) |
710,555 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2025-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
101,242 |
754,481 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2025-03-01 |
4 |
D |
$38.74 |
$374,693 |
D/D |
(9,672) |
76,050 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2025-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,938 |
85,722 |
|
- |
|
Seith Douglas J |
Chief Operating Officer |
|
2025-03-01 |
4 |
D |
$38.74 |
$583,037 |
D/D |
(15,050) |
183,563 |
|
- |
|
Seith Douglas J |
Chief Operating Officer |
|
2025-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,386 |
198,613 |
|
- |
|
Wirick Angela L |
Chief Financial Officer |
|
2025-03-01 |
4 |
D |
$38.74 |
$528,142 |
D/D |
(13,633) |
164,770 |
|
- |
|
Wirick Angela L |
Chief Financial Officer |
|
2025-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
39,333 |
178,403 |
|
- |
|
Privitera Salvatore |
Chief Technical Officer |
|
2025-03-01 |
4 |
D |
$38.74 |
$325,300 |
D/D |
(8,397) |
124,765 |
|
- |
|
Privitera Salvatore |
Chief Technical Officer |
|
2025-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,165 |
133,162 |
|
- |
|
Yount Deborah Lee |
Chief Human Resources Officer |
|
2025-03-01 |
4 |
D |
$38.74 |
$463,369 |
D/D |
(11,961) |
45,578 |
|
- |
|
Yount Deborah Lee |
Chief Human Resources Officer |
|
2025-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,853 |
57,539 |
|
- |
|
Dahlquist Karl S. |
Chief Legal Officer |
|
2025-03-01 |
4 |
D |
$38.74 |
$382,364 |
D/D |
(9,870) |
67,729 |
|
- |
|
533 Records found
|
|
Page 1 of 22 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|